Global PEGylated Proteins Market Professional Survey Report 2018

June 2018 | 101 pages | ID: GB239F3AF53EN
QYResearch

Abstracts

This report studies the global PEGylated Proteins market status and forecast, categorizes the global PEGylated Proteins market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturers and suppliers lose their bargaining power. Consumers are able to purchase competitor's products if they are not satisfied with product price or quality. In order for suppliers to tackle the challenge of threat of substitutes, they have to innovate products which meet the needs of their target market segments.

The global PEGylated Proteins market is valued at 3230 million US$ in 2017 and will reach 4180 million US$ by the end of 2025, growing at a CAGR of 3.8% during 2018-2025.

The major manufacturers covered in this report

• ENZON Pharmaceuticals
• Merck Sharp & Dohme
• Roche
• Pfizer
• Amgen
• UCB
• Crealta (Savient)

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Colony Stimulating Factors
• Interferons
• Erythropoietin (EPO)
• Recombinant Factor Viii
• Monoclonal Antibodies
• Others

By Application, the market can be split into

• Cancer Treatment
• Hepatitis
• Chronic Kidney Disease
• Leukemia
• SCID
• Rheumatoid Arthritis & Crohn's Disease
• Others

The study objectives of this report are:

• To analyze and study the global PEGylated Proteins capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
• Focuses on the key PEGylated Proteins manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of PEGylated Proteins are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
PEGylated Proteins Manufacturers
PEGylated Proteins Distributors/Traders/Wholesalers
PEGylated Proteins Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the PEGylated Proteins market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global PEGylated Proteins Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF PEGYLATED PROTEINS

1.1 Definition and Specifications of PEGylated Proteins
  1.1.1 Definition of PEGylated Proteins
  1.1.2 Specifications of PEGylated Proteins
1.2 Classification of PEGylated Proteins
  1.2.1 Colony Stimulating Factors
  1.2.2 Interferons
  1.2.3 Erythropoietin (EPO)
  1.2.4 Recombinant Factor Viii
  1.2.5 Monoclonal Antibodies
  1.2.6 Others
1.3 Applications of PEGylated Proteins
  1.3.1 Cancer Treatment
  1.3.2 Hepatitis
  1.3.3 Chronic Kidney Disease
  1.3.4 Leukemia
  1.3.5 SCID
  1.3.6 Rheumatoid Arthritis & Crohn's Disease
  1.3.7 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PEGYLATED PROTEINS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of PEGylated Proteins
2.3 Manufacturing Process Analysis of PEGylated Proteins
2.4 Industry Chain Structure of PEGylated Proteins

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PEGYLATED PROTEINS

3.1 Capacity and Commercial Production Date of Global PEGylated Proteins Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global PEGylated Proteins Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global PEGylated Proteins Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global PEGylated Proteins Major Manufacturers in 2017

4 GLOBAL PEGYLATED PROTEINS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global PEGylated Proteins Capacity and Growth Rate Analysis
  4.2.2 2017 PEGylated Proteins Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global PEGylated Proteins Sales and Growth Rate Analysis
  4.3.2 2017 PEGylated Proteins Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global PEGylated Proteins Sales Price
  4.4.2 2017 PEGylated Proteins Sales Price Analysis (Company Segment)

5 PEGYLATED PROTEINS REGIONAL MARKET ANALYSIS

5.1 North America PEGylated Proteins Market Analysis
  5.1.1 North America PEGylated Proteins Market Overview
  5.1.2 North America 2013-2018E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E PEGylated Proteins Sales Price Analysis
  5.1.4 North America 2017 PEGylated Proteins Market Share Analysis
5.2 Europe PEGylated Proteins Market Analysis
  5.2.1 Europe PEGylated Proteins Market Overview
  5.2.2 Europe 2013-2018E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E PEGylated Proteins Sales Price Analysis
  5.2.4 Europe 2017 PEGylated Proteins Market Share Analysis
5.3 China PEGylated Proteins Market Analysis
  5.3.1 China PEGylated Proteins Market Overview
  5.3.2 China 2013-2018E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E PEGylated Proteins Sales Price Analysis
  5.3.4 China 2017 PEGylated Proteins Market Share Analysis
5.4 Japan PEGylated Proteins Market Analysis
  5.4.1 Japan PEGylated Proteins Market Overview
  5.4.2 Japan 2013-2018E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E PEGylated Proteins Sales Price Analysis
  5.4.4 Japan 2017 PEGylated Proteins Market Share Analysis
5.5 Southeast Asia PEGylated Proteins Market Analysis
  5.5.1 Southeast Asia PEGylated Proteins Market Overview
  5.5.2 Southeast Asia 2013-2018E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E PEGylated Proteins Sales Price Analysis
  5.5.4 Southeast Asia 2017 PEGylated Proteins Market Share Analysis
5.6 India PEGylated Proteins Market Analysis
  5.6.1 India PEGylated Proteins Market Overview
  5.6.2 India 2013-2018E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E PEGylated Proteins Sales Price Analysis
  5.6.4 India 2017 PEGylated Proteins Market Share Analysis

6 GLOBAL 2013-2018E PEGYLATED PROTEINS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E PEGylated Proteins Sales by Type
6.2 Different Types of PEGylated Proteins Product Interview Price Analysis
6.3 Different Types of PEGylated Proteins Product Driving Factors Analysis
  6.3.1 Colony Stimulating Factors Growth Driving Factor Analysis
  6.3.2 Interferons Growth Driving Factor Analysis
  6.3.3 Erythropoietin (EPO) Growth Driving Factor Analysis
  6.3.4 Recombinant Factor Viii Growth Driving Factor Analysis
  6.3.5 Monoclonal Antibodies Growth Driving Factor Analysis
  6.3.6 Others Growth Driving Factor Analysis

7 GLOBAL 2013-2018E PEGYLATED PROTEINS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E PEGylated Proteins Consumption by Application
7.2 Different Application of PEGylated Proteins Product Interview Price Analysis
7.3 Different Application of PEGylated Proteins Product Driving Factors Analysis
  7.3.1 Cancer Treatment of PEGylated Proteins Growth Driving Factor Analysis
  7.3.2 Hepatitis of PEGylated Proteins Growth Driving Factor Analysis
  7.3.3 Chronic Kidney Disease of PEGylated Proteins Growth Driving Factor Analysis
  7.3.4 Leukemia of PEGylated Proteins Growth Driving Factor Analysis
  7.3.5 SCID of PEGylated Proteins Growth Driving Factor Analysis
  7.3.6 Rheumatoid Arthritis & Crohn's Disease of PEGylated Proteins Growth Driving Factor Analysis
  7.3.7 Others of PEGylated Proteins Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PEGYLATED PROTEINS

8.1 ENZON Pharmaceuticals
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 ENZON Pharmaceuticals 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 ENZON Pharmaceuticals 2017 PEGylated Proteins Business Region Distribution Analysis
8.2 Merck Sharp & Dohme
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Merck Sharp & Dohme 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Merck Sharp & Dohme 2017 PEGylated Proteins Business Region Distribution Analysis
8.3 Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche 2017 PEGylated Proteins Business Region Distribution Analysis
8.4 Pfizer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Pfizer 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Pfizer 2017 PEGylated Proteins Business Region Distribution Analysis
8.5 Amgen
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Amgen 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Amgen 2017 PEGylated Proteins Business Region Distribution Analysis
8.6 UCB
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 UCB 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 UCB 2017 PEGylated Proteins Business Region Distribution Analysis
8.7 Crealta (Savient)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Crealta (Savient) 2017 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Crealta (Savient) 2017 PEGylated Proteins Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF PEGYLATED PROTEINS MARKET

9.1 Global PEGylated Proteins Market Trend Analysis
  9.1.1 Global 2018-2025 PEGylated Proteins Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 PEGylated Proteins Sales Price Forecast
9.2 PEGylated Proteins Regional Market Trend
  9.2.1 North America 2018-2025 PEGylated Proteins Consumption Forecast
  9.2.2 Europe 2018-2025 PEGylated Proteins Consumption Forecast
  9.2.3 China 2018-2025 PEGylated Proteins Consumption Forecast
  9.2.4 Japan 2018-2025 PEGylated Proteins Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 PEGylated Proteins Consumption Forecast
  9.2.6 India 2018-2025 PEGylated Proteins Consumption Forecast
9.3 PEGylated Proteins Market Trend (Product Type)
9.4 PEGylated Proteins Market Trend (Application)

10 PEGYLATED PROTEINS MARKETING TYPE ANALYSIS

10.1 PEGylated Proteins Regional Marketing Type Analysis
10.2 PEGylated Proteins International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of PEGylated Proteins by Region
10.4 PEGylated Proteins Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PEGYLATED PROTEINS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PEGYLATED PROTEINS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of PEGylated Proteins
Table Product Specifications of PEGylated Proteins
Table Classification of PEGylated Proteins
Figure Global Production Market Share of PEGylated Proteins by Type in 2017
Figure Colony Stimulating Factors Picture
Table Major Manufacturers of Colony Stimulating Factors
Figure Interferons Picture
Table Major Manufacturers of Interferons
Figure Erythropoietin (EPO) Picture
Table Major Manufacturers of Erythropoietin (EPO)
Figure Recombinant Factor Viii Picture
Table Major Manufacturers of Recombinant Factor Viii
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of PEGylated Proteins
Figure Global Consumption Volume Market Share of PEGylated Proteins by Application in 2017
Figure Cancer Treatment Examples
Table Major Consumers in Cancer Treatment
Figure Hepatitis Examples
Table Major Consumers in Hepatitis
Figure Chronic Kidney Disease Examples
Table Major Consumers in Chronic Kidney Disease
Figure Leukemia Examples
Table Major Consumers in Leukemia
Figure SCID Examples
Table Major Consumers in SCID
Figure Rheumatoid Arthritis & Crohn's Disease Examples
Table Major Consumers in Rheumatoid Arthritis & Crohn's Disease
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of PEGylated Proteins by Regions
Figure North America PEGylated Proteins Market Size (Million USD) (2013-2025)
Figure Europe PEGylated Proteins Market Size (Million USD) (2013-2025)
Figure China PEGylated Proteins Market Size (Million USD) (2013-2025)
Figure Japan PEGylated Proteins Market Size (Million USD) (2013-2025)
Figure Southeast Asia PEGylated Proteins Market Size (Million USD) (2013-2025)
Figure India PEGylated Proteins Market Size (Million USD) (2013-2025)
Table PEGylated Proteins Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of PEGylated Proteins in 2017
Figure Manufacturing Process Analysis of PEGylated Proteins
Figure Industry Chain Structure of PEGylated Proteins
Table Capacity and Commercial Production Date of Global PEGylated Proteins Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global PEGylated Proteins Major Manufacturers in 2017
Table R&D Status and Technology Source of Global PEGylated Proteins Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global PEGylated Proteins Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of PEGylated Proteins 2013-2018E
Figure Global 2013-2018E PEGylated Proteins Market Size (Volume) and Growth Rate
Figure Global 2013-2018E PEGylated Proteins Market Size (Value) and Growth Rate
Table 2013-2018E Global PEGylated Proteins Capacity and Growth Rate
Table 2017 Global PEGylated Proteins Capacity (g) List (Company Segment)
Table 2013-2018E Global PEGylated Proteins Sales (g) and Growth Rate
Table 2017 Global PEGylated Proteins Sales (g) List (Company Segment)
Table 2013-2018E Global PEGylated Proteins Sales Price (USD/mg)
Table 2017 Global PEGylated Proteins Sales Price (USD/mg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (g) of PEGylated Proteins 2013-2018E
Figure North America 2013-2018E PEGylated Proteins Sales Price (USD/mg)
Figure North America 2017 PEGylated Proteins Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (g) of PEGylated Proteins 2013-2018E
Figure Europe 2013-2018E PEGylated Proteins Sales Price (USD/mg)
Figure Europe 2017 PEGylated Proteins Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (g) of PEGylated Proteins 2013-2018E
Figure China 2013-2018E PEGylated Proteins Sales Price (USD/mg)
Figure China 2017 PEGylated Proteins Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (g) of PEGylated Proteins 2013-2018E
Figure Japan 2013-2018E PEGylated Proteins Sales Price (USD/mg)
Figure Japan 2017 PEGylated Proteins Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (g) of PEGylated Proteins 2013-2018E
Figure Southeast Asia 2013-2018E PEGylated Proteins Sales Price (USD/mg)
Figure Southeast Asia 2017 PEGylated Proteins Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (g) of PEGylated Proteins 2013-2018E
Figure India 2013-2018E PEGylated Proteins Sales Price (USD/mg)
Figure India 2017 PEGylated Proteins Sales Market Share
Table Global 2013-2018E PEGylated Proteins Sales (g) by Type
Table Different Types PEGylated Proteins Product Interview Price
Table Global 2013-2018E PEGylated Proteins Sales (g) by Application
Table Different Application PEGylated Proteins Product Interview Price
Table ENZON Pharmaceuticals Information List
Table Product Overview
Table 2017 ENZON Pharmaceuticals PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 ENZON Pharmaceuticals PEGylated Proteins Business Region Distribution
Table Merck Sharp & Dohme Information List
Table Product Overview
Table 2017 Merck Sharp & Dohme PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 Merck Sharp & Dohme PEGylated Proteins Business Region Distribution
Table Roche Information List
Table Product Overview
Table 2017 Roche PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 Roche PEGylated Proteins Business Region Distribution
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 Pfizer PEGylated Proteins Business Region Distribution
Table Amgen Information List
Table Product Overview
Table 2017 Amgen PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 Amgen PEGylated Proteins Business Region Distribution
Table UCB Information List
Table Product Overview
Table 2017 UCB PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 UCB PEGylated Proteins Business Region Distribution
Table Crealta (Savient) Information List
Table Product Overview
Table 2017 Crealta (Savient) PEGylated Proteins Revenue (Million USD), Sales (g), Ex-factory Price (USD/mg)
Figure 2017 Crealta (Savient) PEGylated Proteins Business Region Distribution
Figure Global 2018-2025 PEGylated Proteins Market Size (g) and Growth Rate Forecast
Figure Global 2018-2025 PEGylated Proteins Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 PEGylated Proteins Sales Price (USD/mg) Forecast
Figure North America 2018-2025 PEGylated Proteins Consumption Volume (g) and Growth Rate Forecast
Figure China 2018-2025 PEGylated Proteins Consumption Volume (g) and Growth Rate Forecast
Figure Europe 2018-2025 PEGylated Proteins Consumption Volume (g) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 PEGylated Proteins Consumption Volume (g) and Growth Rate Forecast
Figure Japan 2018-2025 PEGylated Proteins Consumption Volume (g) and Growth Rate Forecast
Figure India 2018-2025 PEGylated Proteins Consumption Volume (g) and Growth Rate Forecast
Table Global Sales Volume (g) of PEGylated Proteins by Type 2018-2025
Table Global Consumption Volume (g) of PEGylated Proteins by Application 2018-2025
Table Traders or Distributors with Contact Information of PEGylated Proteins by Region